New Zealand Diabetes Medicine Sales is set to reach $60.31 Million by 2027 from $50.3 Million 2022, increased 5.9% per year. Since 2017, the market was up 4.6% year on year attaining $14,300 Million.
| # | 9 Countries | Million US Dollars | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Canada | 3,780 | 2023 | +14.14% | +15.25% | View data |
| 2 | 2 Italy | 1,450 | 2023 | +2.14% | +5.34% | View data |
| 3 | 3 Australia | 930 | 2023 | +10.37% | +10.77% | View data |
| 4 | 4 Croatia | 589.6 | 2023 | +2.47% | +3.43% | View data |
| 5 | 5 Portugal | 563.1 | 2023 | +3.89% | +8.21% | View data |
| 6 | 6 Denmark | 240.4 | 2023 | +3.26% | +3.62% | View data |
| 7 | 7 Slovakia | 106 | 2023 | +3.21% | +5.19% | View data |
| 8 | 8 New Zealand | 94.4 | 2023 | +21.03% | +18.86% | |
| 9 | 9 Latvia | 37.2 | 2023 | +3.91% | +6.86% | View data |
